TCTMD23h
Genomadix Inc. Announces Health Canada License for Rapid Genetic Test to Aid Therapy Selection for Stroke and Cardiovascular Disease Patients
The Cube CYP2C19 test can be used to aid clinicians in determining therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. Genomadix CubeTM CYP2C19 System identifies the CYP2C19 ...
Free Speech Group Blasts UH For Censoring Law School Presentation
The Foundation for Individual Rights and Expression, a nonpartisan group that monitors colleges, has stepped in to support ...